CCCarmen Campino

Carmen Campino

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Carmen Campino has a total of 108 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sodium Intake Is associated With Endothelial Damage Biomarkers and Metabolic Dysregulation

    by Carmen Campino, Rene Baudrand, Carolina A Valdivia, Cristian Carvajal, Andrea Vecchiola, Alejandra Tapia-Castillo, Alejandro Martínez-Aguayo, Hernán Garcia, Lorena García, Fidel Allende, et al.

    Mounting evidence has associated high sodium (HS) intake with hypertension, cardiovascular disease, and stroke. We investigated whether HS intake modulates the parameters of endothelial damage, inflammation, and oxidative stress. We used a cross-sectional study design including 223 Chilean subjects (6.9–65.0 years old). We measured aldosterone, renin activity, cortisol, cortisone, adiponectin, leptin, hsCRP, interleukin 6 (IL-6), tumor necrosis factor-α (TNF-α), plasminogen activator inhibitor type 1 (PAI-1), metalloproteinase (MMP)-9 and MMP-2 activity, and malondialdehyde. Sodium and creatinine were measured in 24-hour urine samples. The subjects were divided by sodium intake, high sodium (HS): ≥150 mEq/day, n = 118, and adequate sodium (AS): n = 105. We observed a positive correlation between urinary sodium excretion and blood pressure (r = 0.1669, P = 0.0124 for systolic and r = 0.2416, P = 0.0003 for diastolic), glycemia (r = 0.2660, P < 0.0001), and triglycerides (r = 0.1604, P = 0.0175) and a highly significant correlation between sodium excretion and PAI-1 (r = 0.2701, P < 0.0001). An inverse correlation was observed between urinary sodium and HDL-cholesterol (r = −0.2093, P = 0.0018) and adiponectin (r = −0.2679, P < 0.0001). In a linear regression model, urinary sodium excretion remained significantly associated with PAI-1 values even after adjusting for age, gender, and BMI. The HS group had higher blood pressure, glycemia, HOMA-IR, atherogenic index of plasma, and PAI-1 values than the group with AS intake. HS intake is associated with endothelial damage (high PAI-1) and metabolic dysregulation. On the other hand, inflammation and oxidative stress parameters are not modified by sodium intake.


  • Serum Cortisol and Cortisone as Potential Biomarkers of Partial 11β-Hydroxysteroid Dehydrogenase Type 2 Deficiency

    by Cristian A Carvajal, Alejandra Tapia-Castillo, Carolina P Valdivia, Fidel Allende, Sandra Solari, Carlos F Lagos, Carmen Campino, Alejandro Martínez-Aguayo, Andrea Vecchiola, Constanza Pinochet, et al.

    BACKGROUND: Pathogenic variations in HSD11B2 gene triggers the apparent mineralocorticoid excess syndrome (AME). There is scarce information regarding the phenotypes of subjects carrying heterozygous pathogenic variants in HSD11B2 gene. We investigated if serum cortisol/cortisone (F/E) ratio and cortisone are useful for identifying partial 11βHSD2 deficiency in those heterozygous subjects.METHODS: We studied two patients diagnosed with AME and their families carrying either D223N or R213C mutation. We also evaluated 32 healthy control subjects (13 children and 19 adults) to obtain normal references ranges for all measured variables. Case 1: A boy carrying D223N mutation in HSD11B2 gene and Case 2: A girl carrying R213C mutation. We assessed serum F/E ratio and cortisone by HPLC-MS/MS, aldosterone, plasma-renin-activity(PRA), electrolytes, and HSD11B2 genetic analyses.RESULTS: The normal values (median [interquartile range]) in children for serum F/E and cortisone (µg/dl) were 2.56 [2.21–3.69] and 2.54 [2.35–2.88], and in adults were 4.42 [3.70–4.90] and 2.23 [1.92–2.57], respectively. Case 1 showed a very high serum F/E 28.8 and low cortisone 0.46 µg/dl. His mother and sister were normotensives and heterozygous for D223N mutation with high F/E (13.2 and 6.0, respectively) and low cortisone (2.0 and 2.2, respectively). Case 2 showed a very high serum F/E 175 and suppressed cortisone 0.11 µg/dl. Her parents and sister were heterozygous for the R213C mutation with normal phenotype, but high F/E and low cortisone. Heterozygous subjects showed normal aldosterone, PRA, but lower fractional excretion of sodium and urinary Na/K ratio than controls.CONCLUSION: Serum F/E ratio and cortisone allow to identify partial 11βHSD2 deficiencies, as occurs in heterozygous subjects, who would be susceptible to develop arterial hypertension.


  • Polarized epithelial cells release exosomes loaded with miRNAs capable of interacting with HSD11B2 and MR genes

    by Eric Barros, David Ortiz, Carmen Campino, Carolina Valdivia, Alejandra Tapia-Castillo, Jaime Lizama, Fidel Allende, Sandra Solari, Jose Vicente Gonzalez, Alejandro Martinez-Aguayo, et al.

    Arterial hypertension is a major health problem affecting 1.13 billion people worldwide, of which 10% could be due to endocrine pathologies related to the mineralocorticoid receptor (MR) (i.e. primary aldosteronism, 11β-hydroxysteroid dehydrogenase type 2 enzyme (HSD11B2) deficiency). The MR pathway is expressed mainly in placenta, kidney and colon epithelial cells. Current research highlights potential epigenetic regulatory mechanisms for the MR pathway. Here, specific miRNAs are being studied as epigenetic regulators, either present in cells or exosomes (nanovesicles of 40–150 nm diameter) carrying miRNA, RNA, lipids and proteins. Those miRNAs could dynamically influence the onset and progression of the mineralocorticoid arterial hypertension (AH). Aim: To isolate exosomes from polarized epithelial cells and to identify in their cargo miRNAs affecting HSD11B2 and MR gene expression. Methods: The bioinformatic tool mirWalk2.0 was used to determine miRNAs capable to interact with HSD11B2 and MR RNAs. The cell line derived from colon epithelia (Caco-2) cells was cultured and polarized in Transwells. MR pathway genes and miRNAs targeting the MR and HDS11B2 were measured by qPCR. Exosomes from apical and basolateral culture medium were isolated at 24 h of incubation in basal conditions, quantified with NanoSight-NS300 and their specific miRNA content was determined. Results: We identified bioinformatically that miRNA 135b, 644a and miRNA 488, 1205 could interact with the MR and HSD11B2, respectively. Caco-2 cells polarize after 21 days of culture (trans-epithelial resistance (TEER): 114.18 cm2), expressing polarization genes (SLC11A2, SLGT1, ALPI), genes associated to MR pathway (NR3C2, HSD11B2, SCNN1A, SLC12A2, SGK1, ATP1A1) and pre-miRNAs (135b, 644a, 488, 1205). We identified that Caco-2 release 21×109±0.69×109 (apical) and 4.1×109±0.0029×109 (basolateral) extracellular vesicles per ml of which a 36.8 and 38.5% are exosomes with a modal range in 124–125 nm diameter respectively. Preliminary results show expression of miRNA 135b, 644a, 488 and 1205 in apical and basolateral exosomes. Conclusion: Caco-2 cells release five-times more exosomes in the apical than basolateral side, both carrying miRNAs that could interact HSD11B2 and MR gene.

  • PS 10-19 SERUM CORTISONE AND CORTISOL/CORTISONE RATIO AS TOOL TO IDENTIFY SUBJECTS WITH SEVERE AND PARTIAL 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2 DEFICIENCIES

    by Cristian Carvajal, Alejandra Tapia-Castillo, Alejandro Martinez-Aguayo, Carolina Valdivia, Carmen Campino, Rene Baudrand, Fidel Allende, Constanza Pinochet, Virginia Iturrieta, Jaime Lizama, et al.

    To report the phenotype of patients with AME by clinical and biochemical study, and expanding the study to their families and unrelated subjects to assess the value of F/E ratio as a biomarker partial deficiency of 11βHSD2. We evaluated 2 AME patients and their families. Family 1: A 17 years-old male with a homozygous Asp223Asn (D223N) mutation in HSD11B2, his mother (33 years) and sister (8 years); and Family 2: A 2 years-old girl with a homozygous Arg213Cys (R213C) mutation in HSD11B2, his father (30 years), her mother (30 years) and sister (6 years). We measured serum potassium, aldosterone, plasma renin activity (PRA), microalbuminuria, NGAL and F/E ratio (HPLC-MS). Reference ranges (RR), percentiles (p) and cut-off points for F, E and F/E serum were determined on data obtained from adult and pediatric normotensive subjects (F/E children RR: 1.63 to 5.15 and F/E adults RR:2.6–7.8]). Genetic analyses were performed by PCR-HRM and DNA sequencing. Family 1: Index case (mut D223N) with classical AME features and a high serum F/E ratio (28.8 (> p99)). His mother and sister were normotensive and heterozygous for the same mutation D223N without clinical and biochemical abnormalities but with high F/E ratios (13.1 (p97) and 7.4 (p97)), respectively). Family 2: Index case (mut R213C) with classical AME and and a high F/E (175 (>p99)). His father, mother and sister were heterozygous for R123C, and are clinically and biochemically normal except for high F/E ratios (p92, p93 and p85, respectively). A F/E ratio greater than p90 –often associated to a cortisone lesser than p30- in relatives of subjects with AME suggests that partial heterozygous alterations or deficit in HSD11B2 are able to be identified by studying the serum cortisone and F/E ratio without prior clinical or biochemical features of classic AME such as AH, suppressed PRA and hypokalemia.

  • Open Access

    Usefulness and Pitfalls in Sodium Intake Estimation: Comparison of Dietary Assessment and Urinary Excretion in Chilean Children and Adults

    by Carmen Campino, Caroline Hill, Rene Baudrand, Alejandro Martínez-Aguayo, Marlene Aglony, Carmen A. Carrasco, Clarita Ferrada, Carolina Loureiro, Andrea Vecchiola, Rodrigo Bancalari, et al.

    BACKGROUND High sodium intake has been associated with various noncommunicable disease like hypertension, cardiovascular disease, or stroke. To estimate accurately sodium intake is challenging in clinical practice. We investigate the usefulness and limitations of assessing sodium intake simultaneously by dietary assessment and urinary samples in both children and adults. METHODS We used a cross-sectional study design inviting 298 Chilean subjects (74 children and 222 adults) aged between 9 and 66 years of both genders. Sodium intake by dietary assessment was obtained from Chilean food composition data, based on FAO tables. Sodium and creatinine excretion were measured in 24-hour urine samples, in all participants. RESULTS Adequate urinary collection was obtained in 81% of children (59/74) and 61% of adults (135/222). The mean sodium intake by dietary assessment was similar to the sodium excretion in 24 hours (3,121±1,153mg/d vs. 3,114±1,353mg/24h, P = nonsignificant) in children but was significantly lower (3,208±1,284mg/d vs. 4,160±1,651mg/24h, P < 0.001) in adults. In both children and adults, sodium intake correlated with urinary sodium excretion (r = 0.456, P < 0.003 and r = 0.390, P < 0.001, respectively). Secondary analyses also suggested that the dietary assessment was more inaccurate in overweight adult subjects. CONCLUSIONS Our results showed that average sodium intake was higher than recommended in both children and adults (WHO ≤2,000mg/d). The sodium intake estimated by dietary assessment correlated with urinary excretion in all subjects, but in obese adults was more inaccurate than in children. Future studies to validate the appropriate test to assess sodium intake by age and nutritional status are warranted.


  • Adrenal dysregulation in children who were born extremely premature - a pilot study

    by Carmen Campino, Alejandro Martinez-Aguayo, Rene Baudrand, Cristian Carvajal, Hernan Garcia, Marlene Aglony, Rodrigo Bancalari, Lorena Garcia, Carolina Loureiro, Andrea Vecchiola, et al.

    Introduction: The prevalence of hypertension in children and adolescent who were extremely preterm newborns (EP; ≤32 gestational weeks) has been found to be higher than in those born at term. The causes have not been well characterized. Studies support that adrenal dysregulation might be a consequence of prematurity. Objectives: To determinate if children who were EP had higher adrenal hormones and vascular remodeling biomarker than term newborn (≥38 gestational weeks). Design, subjects and methods: A pilot – cross sectional study was design. Children from the community were invited (n=235, range 5.1–15.5 years old); twelve were EP (gestational age between 30 and 32 weeks) and 223 were born at term (gestational age between 38 and 40 weeks). Anthropometric characteristics and aldosterone, plasma renin activity (PRA), aldosterone/PRA ratio (ARR), cortisol and cortisone were measured. Metalloproteinasa 2 (MMP-2) activity was measured as a vascular remodeling biomarker. Results (median): Both groups were comparables in age (10.2 vs 11.6 years; P=0.075), BMI-SDS (1.13 vs 1.18; P=0.434), height-SDS (0.48 vs 0.23; P=0.434) and blood pressure corrected by gender, age and height (systolic index 1.09 vs 1.06, P=0.184 and diastolic index 1.11 vs 1.10 P=0.797). EP newborn vs term newborn showed similar aldosterone (ng/dl): 7.6 vs 6.2 (P=0.439) and PRA (ng/ml per h): 2.16 vs 2.3 (P=0.779) but higher ARR (3.9 vs 2.6 P=0.039) and higher MMP-2 activity (Arbitrary units): 1.88 vs 1.50 (P=0.009). No statistical differences in cortisol, cortisone and cortisol/cortisone ratio were observed. Conclusions: This pilot study showed that children who were extremely preterm newborn have higher ARR and vascular remodeling than children born at term, despite similar blood pressure. Future studies to assess the importance of these findings in early prevention of hypertension are warranted.

  • Open Access

    Polymorphisms in the RAC1 Gene Are Associated With Hypertension Risk Factors in a Chilean Pediatric Population

    by Alejandra Tapia-Castillo, Cristian A. Carvajal, Carmen Campino, Andrea Vecchiola, Fidel Allende, Sandra Solari, Lorena García, Sergio Lavanderos, Carolina Valdivia, Cristobal Fuentes, et al.

    The GTPase Rac1 has been implicated in hypertension as a modulator of mineralocorticoid receptor activity. Our aim is to investigate the frequency of polymorphisms rs10951982 (intron 1, G>A) and rs836478 (intron 3, T>C) in the RAC1 gene and perform association studies with clinical and biochemical parameters in a Chilean pediatric cohort. Two hundred two normotensive (NT) subjects (aged 4–16 years) were divided into 2 groups: NT subjects with hypertensive parents (NH; n = 103) and NT subjects with NT parents (NN; n = 99). We measured markers of inflammation (high-sensitivity C-reactive protein, interleukin 6 (IL-6), interleukin 8, and tumor necrosis factor α), endothelial damage (Plasminogen activator inhibitor-1 metalloproteinase-9, and metalloproteinase-2), and oxidative stress (malondialdehyde). Data were expressed as median and interquartile range (IQR). We found differences in polymorphism rs836478 (intron 3, C>T) in both genotypic (χ2 = 15.2, 2df; P = 0.0005) and allelic (X2=5.5, 1df; P = 0.01) frequencies in NH vs. NN subjects. NH subjects with a TT genotype showed increase MMP9 expression (median = 2.3, IQR - 1.6–3.2; vs. median = 1.6, IQR = 1.6–2.3 AU; P = 0.01) and lower IL-6 expression (median = 8.8, IQR = 7.0–11.8; vs. median = 12.1, IQR = 8.2–14.7 pg/ml; P = 0.02) compared with subjects with TC/CC genotype. No difference in the allelic frequency distribution was seen in the polymorphism rs10951982 (NH vs. NN: χ2=0.2, 1df; P = 0.6). For this SNP, NN subjects with GA/AA genotype showed decreased diastolic BP indexes compared with subjects with native GG genotype (median = 1.08, IQR = 1.0–1.2; vs. median = 0.99, IQR = 0.94–1.1; P = 0.02). We report the frequency of polymorphisms rs836478 and rs10951982 of the RAC1 gene in a Spanish-Amerindian cohort. The polymorphism rs836478 was associated with an increased expression in markers of inflammation and endothelial damage (MMP9 and IL-6) in pediatric subjects with a hypertensive genetic background.


  • Open Access

    Different effects of progesterone and estradiol on chimeric and wild type aldosterone synthase in vitro

    by Andrea Vecchiola, Carlos F Lagos, Cristóbal A Fuentes, Fidel Allende, Carmen Campino, Carolina Valdivia, Alejandra Tapia-Castillo, Tadashi Ogishima, Kuniaki Mukai, Gareth Owen, et al.

    Familial hyperaldosteronism type I (FH-I) is caused by the unequal recombination between the 11beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes, resulting in the generation of a CYP11B1/B2 chimeric gene and abnormal adrenal aldosterone production. Affected patients usually show severe hypertension and an elevated frequency of stroke at a young age. Aldosterone levels rise during pregnancy, yet in pregnant women with FH-1, their hypertensive condition either remains unchanged or may even improve. The purpose of this study was to investigate in vitro whether female sex steroids modulate the activity of chimeric (ASCE) or wild type (ASWT) aldosterone synthase enzymes.


  • 11?-Hydroxysteroid Dehydrogenase Type 2 (11?-HSD2) Activity Decreases with Age in Normotensive Subjects

    by Carmen Campino, Alejandro Martinez-Aguayo, Marlene Aglony, Hernan Garcia, Rodrigo Bancalari, Carolina Avalos, Lilian Bolte, Cristian A Carvajal, Rene Baudrand, Gareth I Owen, et al.

    The prevalence of arterial hypertension increases with age, although the cause in the majority of the patients is unknown. In a previous study, we found that impairment in 11Beta-HSD2 activity resulted in inefficient conversion of cortisol (F) to its inactive metabolite cortisone (E) which may trigger hypertension via the activation of the mineralocorticoid receptor (1). Currently, no information exists in respect to 11Beta-HSD2 activity through the lifetime of a normotensive healthy population.